TD 24.02 RATIONAL: Assessing the clinical utility of HPV ctDNA kinetics as a marker of radiologically undetectable residual disease in human papillomavirus-associated oropharyngeal cancer treated with definitive chemoradiotherapy (Cat A, In development) (#34)
Lachlan McDowell
1
- Princess Alexandra Hospital, Woolloongabba, QLD, Australia
Content is not available at the time of publishing.